Six sectors, covered on both sides.

Therapeutics, diagnostics and medical devices, the providers around them, and the venture, growth and family capital funding them to approval.

A mandate here is a company past its NIH Phase II award, or a trial with its data in hand, before it is in market.

Defense and dual-use technology, space and positioning systems, the manufacturers behind them, and the defense-focused funds and family offices allocating alongside them.

A mandate here is a company already supplying the Department of Defense, or a program past its Phase II award.

Hyperscale and colocation platforms, edge facilities, fiber, and the powered land, interconnection, and PPA positions that underwrite them.

A mandate here is powered land before entitlement, or a regional operator a year from deciding whether to sell.

Generation, transition assets, and the project structures behind them.

A mandate here is development equity before construction, or an offtake contract a lender can size debt against.

Software, semiconductors and sensing hardware, from funded development through recurring revenue.

A mandate here is a company with recurring revenue and no process running, or a founder raising once more before a sale.

Recurring-revenue services businesses and specialty financial platforms.

A mandate here is an owner-held platform reached before a process begins.